Sidenav Mini


Money Monday May 22nd 2023 Morning Stock Newsletter


Stir with a solid 20% ROI on $SPY put of the gate Friday morning. Way to come in with a plan and execute om it! Nice one and done trade to end your week. Congratulations on those amazing profits!!!!

🌟 Good morning team and happy Money Monday! 🌟

I hope everyone had a fantastic weekend and that you are ready for another great week ahead! 👏 Last week was AMAZING in the market as we saw traders locking in some BIG TIME profits. This is the time to LEARN and EARN team as there is fantastic opportunity in this market!

Live Stream is now up and The Pre-market Rundown will begin at 8:45AM. The morning Game Plan Session will start at 9AM followed by Live Market Training/Trading from 9:30AM – 11AM and Private Market Mastery Training from 11AM – 11:30AM 👏 👏 👏

Let’s have an amazing day team.


Stock futures are flat as Wall Street focuses on tense debt ceiling negotiations

Yesterdays top penny stocks:


5 things to know before the stock market opens Monday

Market Briefing:

Stock futures were little changed on Monday morning as traders monitored the negotiations over the U.S. debt ceiling as government officials scramble to avoid a default. Futures for the Dow Jones Industrial Average and S&P 500 futures traded flat, while Nasdaq 100 futures were 0.1% lower. Stocks rose last week despite the uncertainty in Washington. The Nasdaq Composite climbed 3.04%, while the S&P 500 gained 1.65%. The Dow added 0.38%. President Joe Biden and House Speaker Kevin McCarthy, R-Calif., are set to meet Monday to continue negotiations. Treasury Secretary Janet Yellen has said the U.S. could default on its debt as early as June 1. The market has continued to grind higher, led by tech stocks, even in the face of a potential debt default and stubborn inflation. Bank of America strategist Savita Subramanian on Sunday hiked her year-end target for the S&P 500 to 4,300 from 4,000, saying that the focus of companies on efficiency would make earnings more stable and that stocks were not overvalued. “Current valuations are not low, but rarely are low during profits recessions. On cyclically adjusted earnings, valuations argue for price returns of 5% per year for the S&P 500 over the next decade,” Subramanian said in a note to clients. The first-quarter earnings season is winding down, but there are a few notable reports in the coming days, with Zoom Video on Monday and Lowe’s and Dick’s Sporting Goods on Tuesday. The upcoming week has a relatively light slate of economic data, highlighted by a second reading for first-quarter GDP on Thursday and the personal consumption expenditures gauge, the Federal Reserve’s preferred inflation measure, on Friday. The release of the Fed minutes on Wednesday from the May meeting could also shed light on how central bankers are thinking about the possibility of further rate hikes. Fed Chairman Jerome Powell on Friday indicated that stresses in the banking system could slow economic growth and reduce the need for higher interest rates. Traders will also be keeping an eye on JPMorgan Chase’s investor day on Monday.

$AVRO – AVROBIO Announces Agreement To Sell Cystinosis Gene Therapy Program To Novartis For $87.5M

$HEPA – Hepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints

$VECT – MW Ironwood Pharmaceuticals to acquire Swiss biotech VectivBio in deal valued at about $1 billion

$IMMX – Immix Biopharma Unit Says NXC-201 Shows 100% Overall Response Rate in Light Chain Amyloidosis Study

$GHL – Greenhill shares are trading higher after Mizuho announced it would acquire the company for $15 per share.

$MU – China says Micron products failed its cybersecurity review

$ZIM – ZIM Integrated Shipping Services GAAP EPS of -$0.50 misses by $0.28, revenue of $1.37B misses by $220M

$DKNG – DraftKings gains after UBS says share price rally has plenty of legs

Personal Game Plans

$HEPA will be on HIGH WATCH of we can break over $17.53. This stock just released an amazing PR stating they achieved primary and secondary endpoints with their phase 2 trial. This is a nice low float stock that could go on a big time move today. Over $17.53, we have room to $20.00 then $21.80

Earnings This Week


Reddit Top Mentions

Market Overview

Largest Short Interest

Economic Calendar